The Molecular Role of Immune Cells in Dilated Cardiomyopathy

• Published in: Medicina (Kaunas, Lithuania) Vol. 59; no. 7; p. 1246
• Main Authors: Wang, Enping, Zhou, Ruofan, Li, Tiange, Hua, Yimin, Zhou, Kaiyu, Li, Yifei, Luo, Shuhua, An, Qi
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.07.2023; MDPI
• Subjects: Antigens; Autoimmune diseases; B cells; Cardiomyopathy; Cardiomyopathy, Dilated; Cardiovascular disease; Cytokines; Dendritic cells; Development and progression; dilated cardiomyopathy; Epigenetic inheritance; Gene expression; Heart; Heart failure; Homeostasis; immune cells; Immune system; Immunotherapy; Inflammation; Ischemia; Lymphocytes; Medical prognosis; Myocarditis; Neutrophils; Pathogenesis; Pathogens; Pathology; Review; Roles; Transplantation; immune cells; cytokines; immunotherapy; dilated cardiomyopathy
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina59071246

Dilated cardiomyopathy (DCM) is a rare and severe condition characterized by chamber dilation and impaired contraction of the left ventricle. It constitutes a fundamental etiology for profound heart failure and abrupt cardiac demise, rendering it a prominent clinical indication for heart transplantation (HTx) among both adult and pediatric populations. DCM arises from various etiologies, including genetic variants, epigenetic disorders, infectious insults, autoimmune diseases, and cardiac conduction abnormalities. The maintenance of cardiac function involves two distinct types of immune cells: resident immune cells and recruited immune cells. Resident immune cells play a crucial role in establishing a harmonious microenvironment within the cardiac tissue. Nevertheless, in response to injury, cardiomyocytes initiate a cytokine cascade that attracts peripheral immune cells, thus perturbing this intricate equilibrium and actively participating in the initiation and pathological remodeling of dilated cardiomyopathy (DCM), particularly during the progression of myocardial fibrosis. Additionally, immune cells assume a pivotal role in orchestrating the inflammatory processes, which are intimately linked to the prognosis of DCM. Consequently, understanding the molecular role of various immune cells and their regulation mechanisms would provide an emerging era for managing DCM. In this review, we provide a summary of the most recent advancements in our understanding of the molecular mechanisms of immune cells in DCM. Additionally, we evaluate the effectiveness and limitations of immunotherapy approaches for the treatment of DCM, with the aim of optimizing future immunotherapeutic strategies for this condition.